Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study

被引:1
|
作者
Naderian, Mohammadreza [1 ,2 ]
Kolahdoozan, Shadi [1 ]
Sharifi, Amir Sina [1 ]
Garmaroudi, Gholamreza [3 ]
Yaseri, Mehdi [4 ]
Poustchi, Hossein [1 ]
Sohrabpour, Amir Ali [1 ]
机构
[1] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Hlth Educ & Promot, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran
关键词
Cut-off; lean; metabolic syndrome X; Non-alcoholic fatty liver disease; non-obese; RISK-FACTORS; INSULIN-RESISTANCE; ADULT-POPULATION; ADIPOSE-TISSUE; NORMAL-WEIGHT; VISCERAL FAT; NONOBESE; OBESITY; STEATOHEPATITIS; OVERWEIGHT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent data has proven that the WHO (world health organization) cut-off for obesity is not applicable to the Asian population. This study aims to estimate the prevalence of lean NAFLD (non-alcoholic fatty liver disease) in the capital of Iran and extract probable predictors for this growing heath issue in this population. Methods: This is a population-based cross-sectional study on apparently healthy subjects over 18 years of age. The participants were interviewed for baseline demographic and clinical information. They were subsequently referred for physical examination and blood sampling. NAFLD was diagnosed using abdominal ultrasonography by a single expert radiologist. Results: Of 927 eligible participants who entered the study, 314 were lean; BMI (body mass index) <25 kg/m(2). The prevalence of NAFLD was 17.52% (95% Exact CI: 13.48%-22.18%). BMI, SBP (systolic blood pressure), DBP (diastolic blood pressure), total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein) and triglyceride were significantly different in patients with NAFLD. In the final multiple analysis, higher levels of triglyceride, upper SBP and higher BMI even in the range of less than 25 kg/m2 were independent predictors of NAFLD in lean participants. In lean participants with more components of metabolic syndrome, the prevalence of NAFLD increased significantly (all P < 0.01). BMI cut-offs in men and women along with waist circumference cut-off in men could significantly predict the presence of NAFLD in lean patients. After comparing these values, McNemar test showed that BMI cut-offs are more robust than waist circumference cut-offs for predicting the presence of NAFLD in lean subjects (P < 0.01). Conclusion: The prevalence of NAFLD in lean subjects in a sample of Iranian population is 17.52%. Hypertriglyceridemia, higher SBP, and higher BMI especially over 23.2 are independent factors associated with the presence of NAFLD in lean subjects.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [1] Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study
    Khayyat, Yasir Mohammed
    PHYSIOLOGICAL REPORTS, 2021, 9 (14):
  • [2] Dietary patterns in Brazilian patients with non-alcoholic fatty liver disease: a cross-sectional study
    Ferolla, Silvia Marinho
    Abreu Ferrari, Teresa Cristina
    Pereira Lima, Maria Luiza
    Reis, Tamara Oliveira
    Tavares-, Wilson Campos, Jr.
    Melo Couto, Osvaldo Flavio
    Texeira Vidigal, Paula Vieira
    Fausto, Maria Arlene
    Couto, Claudia Alves
    CLINICS, 2013, 68 (01) : 11 - 17
  • [3] Beverage consumption in patients with metabolic syndrome and its association with non-alcoholic fatty liver disease: a cross-sectional study
    Kositamongkol, Chayanis
    Ngaohirunpat, Sorawis
    Samchusri, Supawit
    Chaisathaphol, Thanet
    Srivanichakorn, Weerachai
    Washirasaksiri, Chaiwat
    Auesomwang, Chonticha
    Sitasuwan, Tullaya
    Tinmanee, Rungsima
    Sayabovorn, Naruemit
    Charatcharoenwitthaya, Phunchai
    Phisalprapa, Pochamana
    FRONTIERS IN NUTRITION, 2024, 11
  • [4] Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study
    Mengyan Xu
    Rui Gong
    Jiao Xie
    Sanping Xu
    Shi Wang
    Nutrition & Metabolism, 22 (1)
  • [5] Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children
    Bellarosa, Cristina
    Bedogni, Giorgio
    Bianco, Annalisa
    Cicolini, Sabrina
    Caroli, Diana
    Tiribelli, Claudio
    Sartorio, Alessandro
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [6] Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study
    Paudel, Mukesh S.
    Tiwari, Awadhesh
    Mandal, Amrendra
    Shrestha, Barun
    Kafle, Paritosh
    Chaulagai, Baikuntha
    Sudhamshu, K. C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [7] Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
    Adejumo, Adeyinka Charles
    Alliu, Samson
    Ajayi, Tokunbo Opeyemi
    Adejumo, Kelechi Lauretta
    Adegbale, Oluwole Muyiwa
    Onyeakusi, Nnaemeka Egbuna
    Akinjero, Akintunde Micheal
    Durojaiye, Modupeoluwa
    Bukong, Terence Ndonyi
    PLOS ONE, 2017, 12 (04):
  • [8] Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
    Li, Youming
    Xu, Chengfu
    Yu, Chaohui
    Xu, Lei
    Miao, Min
    JOURNAL OF HEPATOLOGY, 2009, 50 (05) : 1029 - 1034
  • [9] Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study
    Adrian, Therese
    Sorensen, Ida M. H.
    Knop, Filip K.
    Bro, Susanne
    Ballegaard, Ellen L. F.
    Nordestgaard, Borge G.
    Fuchs, Andreas
    Kofoed, Klaus F.
    Kuhl, Jorgen T.
    Sigvardsen, Per E.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (10) : 1927 - 1934
  • [10] Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran
    Mansour-Ghanaei, Fariborz
    Joukar, Farahnaz
    Mobaraki, Sahar Najafi
    Mavaddati, Sara
    Hassanipour, Soheil
    Sepehrimanesh, Masood
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1591 - 1596